Automation remained a quintessential force throughout 2024 in shaping the biopharma industry. 2025 on the other hand is experiencing advanced applications of automated tools and enablers in different aspects of drugs life cycles. PharmaShots through this magazine navigates automated packaging by decrypting the complexities of automation.
The magazine unfolds the role of automation in biopharma…
Shots:
Precision Medicine is a rapidly evolving field offering targeted treatments for optimal patient care
Education around testing is a critical need as many barriers exist that create practice gaps to patient identification
Testing State Awareness (TSA) is a critical component that needs to complement Brand and Disease State Awareness campaigns
Anton Yarovoy, Group Product…
In the CXO Talks podcast, PharmaShots spoke with Ali Jannati, Director of Cognitive Science at Linus Health. Ali eloquently highlighted Linus’ journey to becoming a leader in digital brain health through its innovative digital cognitive assessment platform
He emphasized the importance of digital biomarkers in evaluating brain function by capturing subtle nuances and response latencies,…
Emerging technologies holds a promising foothold in redefining the aspects of preventative, diagnostic, therapeutic, and patient care in the healthcare landscape. 3D Bioprinting offers innovative approach to addressing unmet healthcare needs with efficacious precision medicine in life-threatening conditions and developing therapies and medical devices that mimic complex human physiology.
In April, PharmaShots Magazine is exploring…
CAR T-cell therapies hold a promising foothold in addressing unmet healthcare needs. Arcellx, a clinical-stage biotech company, is steadfastly exploring the potential of cell therapy in RRMM and generalized myasthenia gravis patients with its lead asset anito-cel.
During presentations at ASH, anito-cel demonstrated no delayed neurotoxicity in both P-1 and pivotal P-II clinical trials for multiple myeloma.…
Did you know that 60 percent of pharmaceutical production is outsourced? As drug development costs rise, CDMOs have become safe havens for biopharma companies by offering scalable, cost-effective, and cutting-edge technology solutions for drug development and manufacturing.
In March, PharmaShots Magazine is navigating the evolving Biopharma CDMO frontier by decoding trends, illustrative infographics, thought-provoking articles,…
After successfully navigating the healthcare landscapes of the US, EU, and China, PharmaShots Magazine brings a comprehensive take on the Japanese Healthcare System. Japan ranked second in healthcare innovation owing to diverse positive parameters like advanced medical infrastructure, learned professionals, and more. In 2023, Japan allocated 11.4 percent of its GDP to enhancing healthcare capabilities. …
Shots:
The 43rd Annual J.P. Morgan Conference took place from 13th to 16th January in San Francisco, USA. J.P. Morgan Healthcare Conference serves as a pioneering hub that features presentations and dialogues on the advances of the healthcare industry by bringing healthcare professionals, researchers, manufacturers, and other healthcare stakeholders to one platform.
Innovation remained the…
For the past two months, we focused on US Healthcare and the European Healthcare systems. This month we are explored China’s Healthcare system by diving deep into the intricacies of government schemes, regulatory reforms, and trends and practices. In 2023, China spent around 5.4% of its GDP to boost healthcare services across its provinces.
In…
Do you know that several European countries offer European Health Insurance Cards that allow citizens to seek emergency care when they travel? European countries are widely regarded for their superior quality healthcare services. With most European countries offering Universal Coverage for primary care, this magazine aims to navigate the nuances of the European Healthcare System. …

